294 filings
Page 2 of 15
6-K
yk5suyag4k44vj
30 Oct 23
Immuron CEO, Steven Lydeamore to present at AusBioInvest
8:00am
6-K
eeh6 r9r218fcbb
23 Oct 23
Notice of 2023 Annual General Meeting and 21 November 2023 at 10.00 am
8:00am
6-K
umg4dk fmnsl
18 Oct 23
Report of Foreign Private Issuer
6:05am
6-K
emk0wc3i a9du0
11 Oct 23
Immuron achieves record quarterly Travelan® sales
6:09am
6-K
onis1fp7pm ozr3tgf
3 Oct 23
Report of Foreign Private Issuer
9:31pm
6-K
kmdh40zn 2x647csfem
28 Sep 23
Report of Foreign Private Issuer
8:43am
6-K
ddo9lpui0xo
13 Sep 23
Immuron achieves record monthly Travelan® sales
6:02am
6-K
n8eniv4x xjgpxa
11 Sep 23
Immuron CEO, Steven Lydeamore to present at H.C. Wainwright
6:10am
6-K
a7makw6s86ek cnp
30 Aug 23
Preliminary Final Report
6:04am
6-K
0bd2p2bxm 2u18rflv3f
14 Aug 23
Immuron to present at the Military Health System Research Symposium
6:02am
6-K
7e7ej48q4xfd x21wyeh
9 Aug 23
Immuron Receives TGA GMP Clearance
6:01am
6-K
7g67 bnhmz
24 Jul 23
Immuron Announces First Patients Enrolled in Travelan® Clinical Study
9:48pm
6-K
3jzuuqa6
24 Jul 23
Immuron CEO, Steven Lydeamore to present at Bioshares
6:04am
6-K
7oh9bez slpc
11 Jul 23
Report of Foreign Private Issuer
6:03am
6-K
pmds chze
5 Jul 23
Report of Foreign Private Issuer
6:57pm
6-K
jp73ttb6 gbyv
30 Jun 23
Report of Foreign Private Issuer
6:08am
6-K
ueyuqh3xdcdcpv 0l
22 Jun 23
Report of Foreign Private Issuer
6:03am
6-K
ylft231hho34 hr0
7 Jun 23
Immuron CEO, Steven Lydeamore presents at LD Micro
8:00am
6-K
yxpph2lwzrigv7hh9
30 May 23
Report of Foreign Private Issuer
8:00am